Parametric Modeling of Survival Data Based on Human Immune Virus (HIV) Infected Adult Patients under Highly Active Antiretroviral Therapy (HAART): A Case of Zewditu Referral Hospital, Addis Ababa (AA), Ethiopia
DOI:
https://doi.org/10.6000/1929-6029.2016.05.04.2Keywords:
Human immunodeficiency Virus, Acquired immune deficiency syndrome, Parametric Models, HAART, ARTCD.Abstract
In the present article our aim is to model the HIV infected adult patients’ dataset. A retrospective cohort study was conducted in Zewditu Referral Hospital located in Addis Ababa, Ethiopia. Records of patients enrolled between September 2010 and August 2014 were reviewed continuously using patients’Antiretroviral Therapy (ART) unique identification numbers as reference. Kaplan-Meier survival curves and Log-Rank test were used to compare the survival experience of different category of patients. Then we attempted to model the above data with the help of four parametric models namely; Exponential, Weibull, Gompertz, and Log-logistic. All fitted models were compared separately by using AIC and log likelihood. The log-logistic model gave a better description of the time-to-death of HIV infected adult patients than the other models. Based on log-logistic model, age, weight, and functional status, TB screen, World Health Organization (WHO) clinical stage and educational level were found to be the most prognostic factors of time-to-death. Furthermore a high risk of death of patients was found to be associated with lower initial weight, WHO clinical stage IV, lower CD4 count, being ambulatory, bedridden, and TB screened and illiterate.
References
Seoane E, Resino S. Lipid and apoprotein profile in HIV-1-infected patients after CD4-guided treatment interruption. J Acquir Immune Defic Syndr 2008; 48(4): 455-459. https://doi.org/10.1097/QAI.0b013e31817bbc07 DOI: https://doi.org/10.1097/QAI.0b013e31817bbc07
UNAIDS, December 2007 Report.
Mellor JW, Munoz A, Giorqi JV, Margolic JB, Tassonic CJ, Gupta P, et al. Plasma Viral Load and CD+ of HIV-1 infection. Ann Intern Med 1997; 126(12): 946-54. https://doi.org/10.7326/0003-4819-126-12-199706150-00003 DOI: https://doi.org/10.7326/0003-4819-126-12-199706150-00003
Seid A, Getie M, Birlie B, Getachew Y. Joint modeling of longitudinal CD4 cell counts and time-to-default from HAART treatment: a comparison of separate and joint models. Electronic Journal of Applied Statistical Analysis 2014; 7(2): 292-314.
Seage GR, Gatsonis C, Weissman JS, Haas JS, Cleary PD, Fowler FJ, et al. The Boston AIDS Survival Score (BASS): A Multidimensional AIDS severity instrument. American Journal of Public Health 1997; 87(4). https://doi.org/10.2105/AJPH.87.4.567 DOI: https://doi.org/10.2105/AJPH.87.4.567
Xueyan J, Hongzhou L, Yuexin Z, Zengquan Z, Hanhui Y, Qingxia Z, et al. A cross-sectional study of HIV and tuberculosis co infection cases in mainland China. Southern Medical Association 2008; 101(9): 914-917. https://doi.org/10.1097/SMJ.0b013e31817c13ab DOI: https://doi.org/10.1097/SMJ.0b013e31817c13ab
Ang LW, Chow KY, Verghesse I, Chew SK, Leo YS. Measurable predictive factors for progression to AIDS among HIV-infected patients in Singapore. Ann Acad Med Singapore 2005; 34(1): 84-89.
Lawn SD, Little F, Bekker L, Kaplan R, Campbel E, Orrell C, Wood R. Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. AIDS 2009; 23: 335-342. https://doi.org/10.1097/QAD.0b013e328321823f
Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 2006; 367: 1335-13342. https://doi.org/10.1016/S0140-6736(06)68580-2 DOI: https://doi.org/10.1016/S0140-6736(06)68580-2
Lawn SD, Little F, Bekker L, Kaplan R, Campbel E, Orrell C, Wood R. Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. AIDS 2009; 23: 335-342. https://doi.org/10.1097/QAD.0b013e328321823f DOI: https://doi.org/10.1097/QAD.0b013e328321823f
Nakhaee F, Law M. Parametric modeling of survival following HIV and AIDS in the era of highly active anti-retroviral therapy: data from Australia. Eastern Mediterranean Health Journal 2011; 17(3): 233. DOI: https://doi.org/10.26719/2011.17.3.231
Ponnuraja C, Venkatesan P. Survival models for exploring tuberculosis clinical trial data an empirical comparison. Indian Journal of Science and Technology 2010; 2(7): 755-758. DOI: https://doi.org/10.17485/ijst/2010/v3i7.2
Hayat A, Suner A, Uyar B. Comparison of five survival models: breast cancer registry data from Ege University cancer research center. Turkey, J Med Sci 2010; 30(5): 1665-1674. https://doi.org/10.5336/medsci.2009-16200 DOI: https://doi.org/10.5336/medsci.2009-16200
Egger M, Chene G. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy.A collaborative analysis of prospective studies. Lancet 2002; 360: 9327, 119-129. https://doi.org/10.1016/S0140-6736(02)09411-4 DOI: https://doi.org/10.1016/S0140-6736(02)09411-4
Kitahata MM, Gange SJ, Abraham AG. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360(18): 1815-1826. https://doi.org/10.1056/NEJMoa0807252 DOI: https://doi.org/10.1056/NEJMoa0807252
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Haftu Legesse, M.K. Sharma
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:
- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .
